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Objective: The aim of this study was to evaluate a possible synergism between AGe-RAGe and TLR4 signaling and the role of p38 MAPK and NF-kB signaling pathways on 
the modulation of the expression of inflammatory cytokines and proliferation of cells from 
the innate and adaptive immune response. Material and Methods: T lymphocyte (JM) and 
monocyte (U937) cell lines were stimulated with LPS and AGe-BSA independently and 
associated, both in the presence and absence of p38 MAPK and NF-kB inhibitors. Proliferation 
was assessed by direct counting and viability was assessed by a biochemical assay of 
mitochondrial function. Cytokine gene expression for RAGe, CCL3, CCR5, IL-6 and TNF-α 
was studied by RT-PCR and RT-qPCR. Results: RAGe mRNA expression was detected in 
both cell lines. LPS and AGE-BSA did not influence cell proliferation and viability of either 
cell line up to 72 hours. LPS and LPS associated with AGe induced expression of IL-6 and 
TNF-α  in monocytes and T cells, respectively. Conclusions: There is no synergistic effect 
between RAGe and TLR signaling on the expression of IL-6, TNF-α , RAGe, CCR5 and CCL3 
by monocytes and lymphocytes. Activation of RAGe associated or not with TLR signaling 
also had no effect on cell proliferation and survival of these cell types.
Keywords: Periodontal diseases. Diabetes mellitus. Innate immunity. Acquired immunity. 
Advanced glycosylation end products.
INTRODUCTION
Diabetes is a metabolic dysfunction that 
has elevated blood glucose as the hallmark 
characteristic. The circulating glucose interacts 
with several proteins in the plasma leading to the 
formation of advanced glycation end products 
(AGes). These AGes can exert numerous biological 
effects and their accumulation was demonstrated 
in kidney18, atherosclerotic plaques6, heart2 and 
other sites affected by complications associated 
with diabetes. AGes exert their effects by binding 
to their membrane receptor, RAGe (receptor for 
advanced glycation end-products). This receptor is 
able to interact with multiple distinct ligands, acting 
sometimes as a receptor for molecular pattern 
recognition similar to that involved in innate immune 
response17. In the periodontium, the expression of 
RAGe has been shown in the endothelium and the 
basal and spinous layers of the epithelium of the 
sulcus, associated with inflammation. Furthermore, 
gene expression of RAGE is significantly higher in 
the gingival epithelium of patients with diabetes12. 
expression of RAGe in immune cells has also been 
reported, however there is paucity of information on 
regulation of RAGe gene expression in these cells1.
Activation of RAGe signaling involves several 
downstream intracellular signaling pathways, 
including some that are considered relevant for 
the expression of inflammatory mediators, such 
as nuclear factor kappa B (NF-kB) and mitogen-
activated protein kinases (MAPK), including c-Jun 
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N-terminal kinase (JNK), extracellular-regulated 
kinase (eRK) and p3811. RAGe expression is also 
induced by activation of NF-kB, creating a loop that 
increases upregulation of inflammatory response16.
The onset of type 2 diabetes is related to obesity 
and a basal chronic state of inflammation with 
increased expression of inflammatory mediators 
such as TNF-α and IL-6 by macrophages present in 
adipose tissues. This augmented inflammatory state 
eventually results in the development of insulin 
resistance and hyperglycemia28. The activation of 
transcription factors NF-kB and AP-1 (activating 
protein 1) plays a fundamental role in regulating 
gene expression of inflammatory mediators 
through the activation of NF-kB and MAPKinases, 
respectively. It is interesting to note that innate 
immunity signaling via TLRs (particularly TLR4) 
may play an important role in the establishment 
and development of diabetes complications13.
Chemokine receptor 5 (CCR5) was first 
recognized as a co-receptor used by HIV virus 
for entry into immune cells, but its functions in 
the host response have been expanded and CCR5 
is currently considered of relevance in various 
inflammatory processes such as atherosclerosis, 
one of the classic complications of diabetes12. 
Recently, its relevance in the progression of 
periodontal disease was demonstrated in vivo with 
the use of biochemical inhibitor (Met-RANTeS) that 
significantly reduced the inflammatory infiltrate 
and alveolar bone resorption21. Chemokine (CC 
motif) ligand 3 (CCL3), also known as macrophage 
inflammatory protein 1-alpha (MIP-1α), is produced 
primarily by monocytes and activated CD4 + T cells 
and interacts with the chemokine receptors CCR1 
and CCR523. CCL3 primary function is chemotactic 
attraction of monocytes and lymphocytes, and its 
expression is increased in inflamed sites15. Higher 
levels of CCL3 are found in the gingival crevicular 
fluid of patients with periodontal disease compared 
with the gingival crevicular fluid from periodontally 
healthy patients25.
Periodontal disease is a chronic inflammatory 
condition of infectious origin characterized by a 
dense infiltrate of lymphocytes that is considered 
one of the classic complications of diabetes. Since 
most of the observed tissue damage in periodontal 
disease is attributed to the host response to the 
bacterial challenge and considering the marked 
effects of diabetes on the host immune response, 
as indicated by reduced resistance to infections, our 
objective was to determine if there is some type 
of interaction between RAGe and TLR signaling in 
cells of the innate and adaptive immune response.
MATERIAL AND METhODS
Cells and materials
We used established human cell lines of T 
lymphocytes (JM) and monocytes (U937) that 
were grown in RPMI-1640 supplemented with 
10% heat-inactivated fetal bovine serum (FBS), 
100 U/mL penicillin and streptomycin 100 µg/mL 
at 37°C in humidified atmosphere of air and 5% 
CO2. Prior to stimulation in the gene expression 
studies, the cells were routinely de-induced for 
8 h in low (1%) FBS-containing culture medium. 
Lipopolysaccharide from Escherichia coli (serotype 
O55:B5) was purchased from Sigma-Aldrich (St 
Louis, MO, USA) and was diluted in PBS (pH 7.4) 
to 10 mg/mL. Biochemical inhibitor of p38 MAPK, 
SB203580, was purchased from Cell Signaling 
(Danvers, MA, USA). PMA (Phorbol 12-myristate 
13-acetate), Doxorubicin hydrochloride and the 
NF-kB inhibitor Bay 11-7082 were purchased from 
Sigma-Aldrich (St Louis, MO, USA). Cell culture 
medium and supplements were purchased from 
Invitrogen (Life Sciences Corp.).
Preparation of advanced glycation end-
product (AgE)
Bovine serum albumin - fraction V (BSA) was 
diluted in PBS (pH 7.4) at a concentration of 50 
mg/ml and subsequently incubated at 37°C for 
8 weeks with 0.5 M glucose in 0.2 M phosphate 
buffer (PBS) pH 7.4 containing 0.5 mM eDTA. 
The free glucose remaining after this incubation 
was removed by extensive dialysis (12 h) in PBS 
free of Ca and Mg, pH 7.4. The BSA-control has 
been prepared in parallel using the same protocol, 
except for the addition of 0.5 M glucose. The BSA-
AGe and BSA control were aliquoted and stored in 
refrigerator (+4°C) after confirmation of glycation 
by determination of absorbance at 405 nm on a 
spectrophotometer. Absorbance values over 3.0 
in the samples of BSA-AGe and less than 0.1 in 
samples of BSA-control confirmed the extensive 
glycation27.
Viability and cell proliferation
For cell proliferation and viability we used the 
trypan blue dye exclusion assay, JM and U937 
cells were plated in medium with 10% FBS in 48-
well plates at 5x105 cells per well. Analysis of cell 
viability and apoptosis by the intrinsic pathway by 
the mitochondrial enzymatic activity assay, cell 
lines were plated in 96-well plates at 1x106 cells 
per well. Cells for both assays were stimulated with 
PBS (negative control), control-BSA (200 ug/mL), 
AGe-BSA (200 ug/mL), E. coli LPS (100 ng/mL) and 
the combination of AGe-BSA and LPS E. coli, both 
in the presence or absence of biochemical inhibitors 
of p38 MAPK (SB203580, 10 uM) and NF-kB (Bay 
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11-7082, 10 uM). Doxorubicin (10 uM) was used 
as a positive control for induction of cell death. 
Stimulations in these experiments were carried out 
for 24, 48 and 72 h.
Quantitative RT-PCR
JM and U937 cells were plated in low serum 
RPMI at 1x106 cells per well in 48-well plates. After 
a de-inducing period of eight hours, the cells were 
stimulated for 6 hours with BSA-Control, AGe-BSA 
(200 µg/mL) and LPS E. coli (100 ng/mL), both 
alone and associated. These stimulations were 
performed with and without biochemical inhibitors 
of p38 MAPK (SB203580, 10 uM) and NF-kB (Bay 
11-7082, 10 uM), 40 minutes before treatment. 
PMA (10 uM) was used as a positive control. Cells 
were collected by centrifugation and total RNA was 
extracted using an affinity column system, according 
to the instructions of the supplier (RNAqueous, 
Ambion Inc). Concentration was determined by 
the absorbance at 260 nm on a microvolume 
spectrophotometer (NanoVue, Ge Healthcare). 
Samples presenting an A260/A280 ratio between 
1.8 and 2.1 were considered acceptably free 
from contaminants. cDNA was synthesized using 
random hexamer primers and moloney leukemia 
virus reverse transcriptase, according to the 
manufacturer’s instructions (High Capacity Reverse 
Transcription kit, Applied Biosystems). Real-time 
PCR was performed using TaqMan reagents (Applied 
Biosystems) and pre-designed and optimized pairs 
of primers and probe (TaqMan Gene expression 
Assays, Applied Biosystems). Selected target genes 
were RAGe, CCR5 and CCL3. GAPDH was used 
as a housekeeping gene for normalization of the 
results. This reaction was performed in a StepOne 
Plus thermocycler (Applied Biosystems) and the 
results analyzed by ∆(∆Ct), the method using the 
thermocycler’s software.
Semi-quantitative RT-PCR
Extraction and purification of total RNA extraction 
was performed as previously described. The PCR 
reaction was performed in a MyCycler (Bio-
Rad) thermocycler using 2 uL of the RT reaction 
product on a 25 uL total volume PCR reaction mix 
Figure 1- Modulation of cell death in the JM (lymphocyte) cell lineage. Right column corresponds to Trypan Blue Test, and 
Left column to MTS assay. The cell line was stimulated for 24, 48 and 72 hours with E. coli LPS (100 ng/mL) with or without 
AGE-BSA (200 µg/mL) in the presence and absence of p38 MAPK inhibitors (SB203580, 10 µM) and NF-kB (Bay 11-7082, 
10 µM). Bars indicate mean±standard deviation of three independent experiments
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(Promega) in the presence of 100 pmol/uL of each 
gene’s primers (50 pmol/uL of sense and antisense 
primers) for IL-6, TNF-α and GAPDH genes yielding 
products of 408, 313 and 420 bp, respectively. 
The primer pairs used for IL-6  - (accession no.: 
NM000600, annealing temperature – 54°C) was: 
sense 5’- AAAGAGGCACTGGCAGAAAA -3’; antisense 
5’ - GAGGTGCCCATGCTACATTT - 3’; for TNF-α - 
(accession no.: NM000594, annealing temperature 
– 55°C) was: sense 5’-TGAGGTACAGGCCCTCTGAT 
-3’, antisense 5’- TGAGGTACAGGCCCTCTGAT 
- 3’, for GAPDH (accession no.: NM002046, 
annealing temperature 54°C) was sense 5’- 
GTCAGTGGTGGACCTGACCT - 3’; antisense 5’- 
AGGGGTCTACATGGCAACTG - 3’. The PCR products 
were resolved by electrophoresis on 1.5% (w/v) 
agarose gels containing ethidium bromide (0.5 μg/
mL). Digital images of the gels under UV light were 
obtained on a gel documentation system (Image 
Quant 100 – Ge Healthcare) and densitometry 
analysis of the bands corresponding to the PCR 
products was performed using Image J 1.32j 
software (National Institute of Health, USA http://
rsb.info.nih.gov/ij/). The density of the bands 
corresponding to IL-6 and TNF-α was normalized 
to the density of the bands for the housekeeping 
gene GAPDH and expressed as fold change over 
unstimulated control.
Statistical analysis
Data are presented as mean±standard deviation 
and mean±standard error specified in the captions 
of the images. The statistical analysis consisted 
of unpaired Student’s t test to compare the 
results according to the different stimulations. 
The calculations were performed on the statistical 
program GraphPad version 5.00 (La Jolla, CA, USA), 
using a significance level of 95% (p<0.05).
RESULTS
Proliferation and cell death
Stimulation with BSA-AGe or LPS, alone or 
associated, did not influence viability of both 
Figure 2- Modulation of cell death in the U937 (monocyte) cell lineage. Right column corresponds to Trypan Blue Test, and 
left column to MTS assay. The cell line was stimulated for 24, 48 and 72 hours with E. coli LPS (100 ng/mL) with or without 
AGE-BSA (200 µg/mL) in the presence and absence of p38 MAPK inhibitors (SB203580, 10 µM) and NF-kB (Bay 11-7082, 
10 µM). Bars indicate mean±standard deviation of three independent experiments
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cell lines as determined by the trypan blue dye 
exclusion assay. Inhibition of p38 MAPK or NF-kB 
also had no effect on cell viability of lymphocytes 
and monocytes. Positive control (doxorubicin) 
significantly reduced cell viability in all three 
periods, indicating both the susceptibility of cells 
to the induction of apoptosis and the sensitivity of 
the assay. Interestingly, a discrete trend towards 
an increase in cell survival of lymphocytes after 48 
and 72 h of stimulation with LPS in the presence 
of SB203580 and Bay 11-7082 (Figure 1) was 
observed. The intrinsic pathway of apoptosis, 
assessed by MTS reduction assay, which is indicative 
of mitochondrial activity, was also not affected 
by the different stimuli at the 24-hour period, 
except for the positive control (doxorubicin), which 
significantly reduced the mitochondrial activity of 
both cell lines. Stimulation of lymphocytes with 
LPS (alone or associated with AGe-BSA) for 48 
and 72 h slightly increased metabolic activity in 
lymphocytes. Interestingly, stimulation of the cells 
with LPS in the presence of SB203580 increased 
metabolic activity, whereas the opposite effect is 
observed in the presence of Bay 11-7082. Induction 
of apoptosis of lymphocytes by the intrinsic pathway 
with inhibition of NF-kB is also noted at 72 h after 
LPS stimulation. In monocytes, none of the stimuli 
used induced cell death assessed by either method 
in any of the experimental periods (24, 48 and 
72 h), however the positive control (doxorubicin) 
induced cell death, confirming the sensitivity of 
cells to the induction of apoptosis. Inhibition of 
NF-kB reduced viability of monocytes assessed by 
both methods in all experimental periods (24, 48 
and 72 h), independently of stimulation (Figure 2).
Regulation of gene expression - RT-PCR 
and RT-qPCR
expression of RAGe mRNA was detected in 
both lymphocytes and monocytes, but it was not 
regulated by any of the treatments and experimental 
conditions, except for a slight inhibition of gene 
expression with inhibition of NF-kB (Figure 4).
expression of IL-6 mRNA was weakly expressed 
by the lymphocyte cell line and was not modulated 
by the stimuli. Inhibition of p38 MAPK decreased 
expression of IL-6 by this cell line, whereas 
inhibition of NF-kB tended to increase IL-6 basal 
Figure 3- Gene expression (mRNA) of IL-6 and TNF-α evaluated by RT-PCR on human cell lines of T lymphocytes (JM) 
and monocytes (U937) after stimulation for 6 h with E. coli LPS (100 ng/mL) with or without AGE-BSA (200 ug/mL) in the 
presence and absence of p38 MAPK inhibitors (SB203580) and NF-kB (Bay 11-7082) inhibitors. The black bar represents 
the positive control (PMA, 10 nM). Bars indicate mean±standard error of three independent experiments
(*) Represents significant difference p<0.05 compared with control group
(**) Represents significant difference p<0.05 in relation to the corresponding group without inhibitor
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expression and also after stimulation with AGe-
BSA, but not after stimulation with LPS. This 
suggests negative regulation of IL-6 expression by 
NF-kB (Figure 3). Regulation of TNF-α mRNA was 
similar to that observed for IL-6, but in contrast 
to IL-6, TNF-α gene expression was significantly 
induced by PMA (positive control) in this cell 
type. A discrete (but not statistically significant) 
synergistic effect on TNF-α expression is observed 
upon stimulation with AGe-BSA and LPS. p38 
MAPK activity is required for TNF-α expression 
by lymphocytes. On the other hand, NF-kB was a 
negative regulator, since inhibition of this pathway 
increased expression of constitutive and AGe-BSA-
induced expression of TNF-α, with or without LPS 
stimulation. Interestingly, LPS-induced expression 
of TNF-α was dependent on both p38 MAPK and 
NF-kB, in a non-redundant manner (Figure 3).
Constitutive expression of IL-6 mRNA was more 
marked in monocytes and LPS, but not AGe-BSA, 
potently induced IL-6 gene expression. LPS-induced 
IL-6 was not inhibited by AGe-BSA, indicating 
absence of antagonistic effect. IL-6 expression by 
monocytes is primarily dependent of p38 MAPK, 
whereas NF-kB does not play an important role 
(Figure 3). As was observed in lymphocytes, 
TNF-α gene expression in the monocytic cell 
line was induced only by PMA (positive control), 
but not by LPS or AGe-BSA. When these stimuli 
were associated, there was a discrete (but non-
significant) synergistic effect on TNF-α expression. 
p38 MAPK activity was not required for TNF-α 
expression by these cells; but inhibition of NF-kB 
resulted in a slight increase in TNF-α mRNA, a 
negative regulatory effect similar to that observed 
Figure 4- Gene expression (mRNA) for RAGE, CCR5 and CCL3 evaluated by RT-qPCR on cell lines of human T 
lymphocytes (JM) and monocytes (U937) after a 6-hour stimulation with E. coli LPS (100 ng/mL) with or without AGE-BSA 
(200 ug/mL) in the presence and absence of p38 MAPK (SB203580) and NF-kB (Bay 11-7082) inhibitors. Bars indicate 
mean±standard error of three independent experiments
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in lymphocytes (Figure 3).
CCR5 and CCL3 are expressed primarily by 
macrophages/monocyte cells and, as expected, 
constitutive expression by lymphocytes was low. 
Interestingly, stimulation with LPS or AGe-BSA 
inhibited expression of both genes. Inhibition of 
p38 MAPK and NF-kB virtually abrogated expression 
of both CCR5 and CCL3 by lymphocytes. In 
monocytes, expression of CCR5 mRNA was reduced 
by the stimuli, except when LPS and AGe-BSA were 
associated. p38 MAPK activity, but not NF-kB, was 
required for constitutive and LPS associated with 
AGe-BSA expression of CCR5 (Figure 4). CCL3 
gene expression was potently induced by PMA in 
monocytes. LPS, alone or combined with AGe-BSA, 
was also a strong inducer of CCL3 mRNA; and this 
induction was dependent on NF-kB, and not p38 
MAPK, activity (Figure 4).
DISCUSSION
AGe-BSA and LPS, alone or associated, did 
not induce cell death in human lymphocytes and 
monocytes. Resistance to apoptosis did not require 
activation of p38 MAPK or NF-kB. We have not 
observed a synergistic or antagonistic interaction 
between the activation of RAGe and TLR4 in 
these cell lines. Our negative finding is contrary 
to previous results of a dose-related increase on 
cell death with increasing concentrations (50, 
100, 200 and 400 ug/mL) of AGe-BSA in the 
same lymphocytic cell line (JM cells) (10). A 50% 
decrease on cell viability (assessed by trypan blue 
dye exclusion and MTT assays) was observed with 
the same concentration of AGe-BSA (200 ug/mL). 
However, the experimental period was 5 days, as 
opposed to 1, 2 and 3 days in our study. Lower 
concentrations of AGe-BSA (1, 10 and 100 ug/mL) 
are not capable of inducing apoptosis in human 
basophils, which was only observed with high 
concentrations (1,000 ug/mL) at 48 h8. Activation 
of RAGe is associated with increased cell survival of 
eosinophils stimulated with S100B, a RAGe ligand, 
over a period of 48 hours, which is similar to our 
findings in the same experimental period5. The 
role of RAGe activation in increased cell survival is 
also suggested by a report of a positive correlation 
between the expression of RAGe and cell viability in 
neoplastic pancreatic cells8. Inhibition of p38 MAPK 
did not modulate apoptosis of T lymphocytes and 
monocytes in the presence and absence of RAGe 
and TLR4 agonists, and similar findings are reported 
in literature in T lymphocytes and monocytes30. Our 
observation of a discrete decrease on cell survival 
upon inhibition of NF-kB pathway is supported by 
literature7. The activation of TLR4 with LPS from E. 
coli at a concentration of 100 ng/mL did not increase 
cell proliferation or cell death and this lack of effect 
may be related with the concentration of LPS used. 
Schacter, et al.22 (1981) tested the cytotoxicity 
of E. coli LPS in human PBMC using increasing 
concentrations from 0.2 to 200 ug/mL. Increased 
cell death was observed initially at 2 ug/mL, with 
the maximum peak (a modest 11% of cell death) 
at 20 ug/mL22.
Both cell lines expressed RAGe mRNA, and this 
expression was not regulated by the stimuli, but 
was slightly (although not statistically significantly) 
dependent on NF-kB in lymphocytes. even though 
p38 MAPK was not relevant for regulation of RAGe 
gene expression, considering that this signaling 
pathway is activated downstream of RAGe, it 
may be involved in the biological effects mediated 
by RAGe activation in both monocytes and in 
lymphocytes9,24.
Constitutive expression of IL-6 mRNA was 
detected on T lymphocytes, and stimulation with 
AGe-BSA or LPS alone significantly inhibited 
expression of IL-6; an effect that was not observed 
when these stimuli were combined. Thus, although 
we have not observed a synergistic effect between 
TLR4 and RAGe, the simultaneous stimulation 
of these receptors eliminated the inhibitory 
effect on IL-6 gene expression verified when 
either receptor was activated independently. In 
monocytes, expression of IL-6 was higher than 
in lymphocytes and these cells were also more 
responsive to stimulation with PMA (positive 
control) and LPS, but not by AGe-BSA. Interestingly, 
the simultaneous activation of RAGe and TLR4 
resulted in no antagonistic or synergistic effects. 
Activation of RAGe with AGe-BSA did not modulate 
expression of IL-6, but it also did not attenuate 
the induction associated with LPS when the stimuli 
were associated. expression of IL-6 mRNA by both 
lymphocytes and monocytes was dependent on 
p38 MAPK pathway but not NF-kB. These data are 
consistent with other studies evaluating the role 
of p38 MAPK on IL-6 gene expression in different 
cell types14,19,20,29.
PMA-induced expression of TNF-α in both 
lymphocytes and monocytes, and simultaneous 
activation of RAGe and TLR4, resulted in a slight 
synergistic effect in the induction of TNF-α mRNA 
in both cell types. p38 MAPK pathway had opposite 
roles in regulation of TNF-α after simultaneous 
stimulation with AGe-BSA and LPS: in lymphocytes, 
inhibition of p38 MAPK decreased expression 
of TNF-α; whereas, in monocytes, inhibition of 
p38 MAPK caused a slight (but not statistically 
significant) increase in TNF-α mRNA. In both 
lymphocytes and monocytes, NF-kB signaling 
was not relevant for regulation of TNF-α gene 
expression.
Modulation of expression of the chemokine 
CCL3 and its receptor CCR5 was evaluated as a 
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manner of obtaining information on the effects 
of activation of TLR4 and RAGe in modulating the 
interaction between innate and adaptive responses. 
expression of CCR5 in T lymphocytes was lower in 
comparison with monocytes, as expected based on 
the literature26,31. RAGe and TLR4 stimulation, alone 
and associated, decreased CCR5 gene expression in 
T lymphocytes, whereas the combined activation of 
these receptors did not affect CCR5 expression in 
monocytes. In both cell types, expression of CCR5 
was dependent on both p38 MAPK (constitutive and 
induced by LPS) and NF-kB (only after stimulation 
with LPS and AGe-BSA associated).
Similarly to CCR5 gene, CCL3 mRNA expression 
was higher in monocytes. In lymphocytes, as 
observed for the regulation of CCR5, all stimuli 
tended to reduce expression of CCL3, and inhibition 
of p38 MAPK or NF-kB nearly abrogated expression 
in these cells. In monocytes, activation of TLR4 
caused a marked induction of CCL3 mRNA, and this 
induction was dependent of NF-kB pathway signaling 
but not of p38 MAPK activity. Activation of RAGe in 
monocytes did not regulate CCL3 expression, but 
when TLR4 and RAGe were simultaneously activated 
there was no attenuation of the inductive effect of 
LPS. Other studies have linked the expression of 
this chemokine with p38 MAPK pathway and NF-kB 
activation3,4.
CONCLUSION
In conclusion, there was no synergism between 
RAGe and TLR4 receptors on modulation of cell 
death and inflammatory gene expression in cell 
lines of innate (U937) and adaptive (JM) immune 
response.
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